STOCK TITAN

IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
IDEXX Laboratories, Inc. (NASDAQ: IDXX) published its 2022 Corporate Responsibility Report, highlighting progress against ESG goals and introducing a new framework aligning ESG initiatives with long-term strategy. The report focuses on environmental and social priorities, including expanded product enhancements, support for veterinary mental health, gender balance in management roles, career progression programs, pay equity assessment, GHG emissions reduction strategy, and transition to environmentally friendly packaging and vehicles.
Positive
  • None.
Negative
  • None.

The 2022 report, "Purpose-Driven Progress," introduces a new framework that aligns IDEXX's ESG goals and initiatives with its long-term strategy and Purpose

WESTBROOK, Maine, July 25, 2023 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published its 2022 Corporate Responsibility Report, highlighting progress against the environmental, social, and governance (ESG) goals it announced last year. The report also introduces a framework to focus and prioritize the company's ESG goals and initiatives. The framework includes three pillars focused on the environmental and social priorities most important to IDEXX's stakeholders and business, underpinned by strong governance, policies, and systems infrastructure.

The Care We Advance
IDEXX brings clarity to a complex world through diagnostic and software solutions to support longer, fuller lives for pets and those who care for them. Key highlights from the 2022 report include these:

  • Offered eight new product, service, and software solution enhancements, including expanded Fecal Dx® antigen testing by adding flea tapeworm detection and new markers for the IDEXX 4Dx® Plus Test.
  • Revealed opportunities to increase veterinary practice productivity while maintaining quality of care in the publication Finding the Time: Empowering Veterinary Teams to Get the Most Out of Every Day.
  • Expanded support for veterinary mental health and well-being as part of the IDEXX Foundation's 60 initiatives in 20+ countries.

The People We Support
IDEXX strives to foster a collaborative and inclusive workplace that empowers employees to develop and grow and find purpose and fulfillment in all they do. Key highlights from the 2022 report include these:

  • Maintained gender balance with 49% of global management roles held by women.
  • Expanded career progression programs, such as career ladders and leadership development resources, for frontline employees.
  • Completed 2022 pay equity assessment, confirming that global pay practices are fair and equitable.

The Planet We Share
IDEXX is committed to reducing its environmental footprint. Key highlights from the 2022 report include these:

  • Outlined greenhouse gas (GHG) emissions reduction strategy, including key long-term projects that will help IDEXX reach its goals established in 2022.
  • Transitioned to environmentally friendly insulated packaging for European cold consumables shipments, avoiding more than 190,000 pounds (estimated) of polystyrene foam per year in Europe, complementing ongoing sustainable packaging initiatives in Australia and North America.
  • Advanced the transition of company-owned vehicles to hybrid and electric models.

"This year's report coincides with IDEXX celebrating its 40th anniversary," said Jay Mazelsky, IDEXX President and Chief Executive Officer. "I feel a deep sense of pride in how we continue to fulfill our Purpose and create long-term value for our stakeholders by advancing care for people and animals, protecting the planet we share, and supporting colleagues and communities where we live and work."

IDEXX's 2022 report once again focuses on IDEXX's key ESG topics in alignment with reporting standards and frameworks, such as those released by the Sustainability Accounting Standards Board and the Task Force on Climate-Related Financial Disclosures as well as our business strategy. Read the 2022 Corporate Responsibility Report here.

About IDEXX
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs nearly 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit idexx.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/idexx-releases-2022-corporate-responsibility-report-providing-environmental-social-and-governance-updates-301884618.html

SOURCE IDEXX Laboratories, Inc.

FAQ

What did IDEXX publish?

IDEXX published its 2022 Corporate Responsibility Report, highlighting progress against ESG goals and introducing a new framework aligning ESG initiatives with long-term strategy.

What are the key highlights of the 2022 report?

The report includes expanded product enhancements, support for veterinary mental health, gender balance in management roles, career progression programs, pay equity assessment, GHG emissions reduction strategy, and transition to environmentally friendly packaging and vehicles.

What is IDEXX's commitment to reducing its environmental footprint?

IDEXX is committed to reducing its environmental footprint through a GHG emissions reduction strategy, transition to environmentally friendly packaging for shipments, and the advancement of company-owned vehicles to hybrid and electric models.

IDEXX Laboratories, Inc.

NASDAQ:IDXX

IDXX Rankings

IDXX Latest News

IDXX Stock Data

44.67B
82.19M
0.93%
92.76%
2.11%
In-Vitro Diagnostic Substance Manufacturing
Manufacturing
Link
United States of America
WESTBROOK

About IDXX

idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an